Lefufuru la Shark

Litaba

• Mohlomong ha e sebetse bakeng sa ...
• Bopaki bo sa lekaneng ba ho lekanya katleho ea ...
• Litlhokomelo le litemoso tse khethehileng:

Shark cartilage (lisele tse thata tse rekang tse fanang ka ts'ehetso, joalo ka lesapo) tse sebelisetsoang bongaka li tsoa haholo ho lishaka tse tšoasitsoeng Leoatleng la Pacific. Mefuta e 'maloa ea lihlahisoa tse entsoeng ka lefufuru la shark ho kenyelletsa squalamine lactate, AE-941 le U-995.

Shark cartilage e sebelisoa haholo bakeng sa mofetše. Shark cartilage e boetse e sebelisetsoa osteoarthritis, plaque psoriasis, tahlehelo ea pono e amanang le lilemo, pholiso ea leqeba, tšenyo ho leihlo la leihlo ka lebaka la lefu la tsoekere, le ho ruruha ha mala (enteritis).

Batho ba bang ba tlotsa lefufuru ka ho toba letlalong bakeng sa ramatiki le psoriasis.

Batho ba bang ba tlotsa lefu la shark lefifing la mofetše.

Meriana ea Tlhahisoleseling e Akaretsang e sebetsa hantle ho ipapisitsoe le bopaki ba mahlale ho latela sekala se latelang: E ​​ea sebetsa, e ka sebetsa hantle, mohlomong ea sebetsa, mohlomong e sa sebetse, mohlomong e sa sebetse, e sa sebetse ebile e sa lekana Bopaki bo lokelang ho lekanyetsoa.

Likarolo tsa katleho ea LEKHOTLA SHARK ke tse latelang:

Mohlomong ha e sebetse bakeng sa ...

• Kankere. Boholo ba lipatlisiso bo bontša hore ho nka lefufuru ka molomo ha ho thuse batho ba nang le mofetše o tsoetseng pele, o neng o kile oa alafshoa oa letsoele, kolone, matšoafo, tšoelesa ea senya kapa boko. Hape ha ho bonahale eka e ruisa batho ba nang le lymphoma e tsoetseng pele, eo pele e neng e tšoaroa e seng ea Hodgkin. Shark cartilage ha e e-so ithutoe ho batho ba nang le mofetše o sa tsoelang pele.

Bopaki bo sa lekaneng ba ho lekanya katleho ea ...

• Hlahala ea mofetše e bitsoang Kaposi sarcoma. Ho na le litlaleho tsa hore ho sebelisa lefufuru letlalong la shaka ho ka fokotsa lihlahala tse bitsoang Kaposi sarcoma. Lihlahala tsena li atile haholo bathong ba nang le HIV.
• Osteoarthritis. Ha li sebelisoa letlalong, ho tlalehoa hore lihlahisoa tse nang le lefufuru hammoho le lisebelisoa tse ling li fokotsa matšoao a ramatiki. Leha ho le joalo, phomolo efe kapa efe ea matšoao e kanna ea ba ka lebaka la motsoako oa camphor eseng lisebelisoa tse ling. Ntle le moo, ha ho na lipatlisiso tse bonts'ang hore lefufuru le kenella letlalong.
• Psoriasis. Phuputso ea pele ho batho ba nang le plaque psoriasis e bontša hore karolo e itseng ea shark cartilage (AE-941) e ntlafatsa ponahalo ea maballo le ho fokotsa ho hlohlona ha e nkuoa ka molomo kapa e sebelisoa letlalong.
• Mofuta oa mofets'e oa liphio o bitsoang renal cell carcinoma. Ho nka lero le itseng la shark cartilage (AE-941) ka molomo ho ka eketsa ho pholoha ho bakuli ba nang le renal cell carcinoma.
• Tahlehelo ea pono e amanang le lilemo.
• Pholiso ea maqeba.
• Maemo a mang.

Bopaki bo eketsehileng boa hlokahala ho lekola lefufuru la lishaka bakeng sa ts'ebeliso ena.

Shark cartilage e ka thibela kholo ea methapo e mecha ea mali e hlokahalang bakeng sa mofetše ho hola. E kanna ea boela ea thibela kholo ea methapo ea mali ho lisosa tsa psoriasis. Sena se ka thusa ho folisa maqeba ana.

Shark lefufuru ke MOTS'ELISI TS'IU bakeng sa batho ba bangata ha ba nooa ka molomo ho fihlela ho likhoeli tse 40 kapa ha ba tlotsoa letlalong ho fihlela libeke tse 8.

E ka baka tatso e mpe molomong, ho nyekeloa ke pelo, ho hlatsa, ho halefa ke mpa, ho sokela, khatello e tlase ea mali, ho tsekela, tsoekere e phahameng maling, maemo a phahameng a khalsiamo, bofokoli le mokhathala. E kanna ea baka ho se sebetse ha sebete. Lihlahisoa tse ling li na le monko o monate le tatso.

Litlhokomelo le litemoso tse khethehileng:

Bokhachane le ho anyesa: Ha ho na leseli le lekaneng le tšepahalang mabapi le polokeho ea ho nka lefufuru haeba u le moimana kapa u anyesa. Lula ka lehlakoreng le sireletsehileng 'me u qobe tšebeliso.

"Maloetse a itšireletsang" a kang multiple sclerosis (MS), lupus (systemic lupus erythematosus, SLE), ramatiki ea ramatiki (RA), kapa maemo a mang: Lefufuru la Shark le ka etsa hore sesole sa 'mele se sebetse haholoanyane. Sena se ka eketsa matšoao a mafu a ikemetseng. Haeba u na le e 'ngoe ea maemo ana, ho molemo ho qoba ho sebelisa lefufuru.

Maemo a phahameng a calcium (hypercalcemia): Lefufuru la Shark le ka eketsa maemo a khalsiamo, ka hona ha ea lokela ho sebelisoa ke batho bao maemo a calcium a seng a le holimo haholo.

E itekanetse

E-ba hlokolosi ka motsoako ona.

Meriana e fokotsang sesole sa 'mele (Immunosuppressants)

Lefufuru la Shark le ka eketsa sesole sa 'mele. Ka ho eketsa sesole sa 'mele, shark lefufuru le ka fokotsa katleho ea meriana e fokotsang sesole sa' mele.

Meriana e meng e fokotsang sesole sa 'mele e kenyelletsa azathioprine (Imuran), basiliximab (Simulect), cyclosporine (Neoral, Sandimmune), daclizumab (Zenapax), muromonab-CD3 (OKT3, Orthoclone OKT3), mycophenolate (CellCept), tacrolimus (FK506, Prograf ), sirolimus (Rapamune), prednisone (Deltasone, Orasone), corticosteroids (glucocorticoids), le tse ling.

K'halsiamo

Lefufuru la Shark le ka phahamisa maemo a khalsiamo. Ho na le ngongoreho ea hore ho e sebelisa hammoho le li-supplement tsa calcium ho ka etsa hore likhalsiamo li phahame haholo.

Lero la tholoana

Lero la litholoana le nang le asiti le kang lamunu, apole, morara kapa tamati le ka theola matla a lefufuru ha metsotso e ntse e feta. Haeba lefufuru le eketsoa ka lero la litholoana, le lokela ho eketsoa pele le sebelisoa.

Tekanyo e loketseng ea lefufuru ea shark e latela lintlha tse 'maloa tse kang lilemo tsa mosebelisi, bophelo bo botle le maemo a mang a mangata. Nakong ena ha ho na tlhaiso-leseling e lekaneng ea mahlale ho tseba hore na ho na le litekanyo tse kae tse loketseng lefu la lefufuru. Hopola hore lihlahisoa tsa tlhaho ha se kamehla li sireletsehileng mme litekanyetso li ka ba tsa bohlokoa. Etsa bonnete ba hore u latela litaelo tse nepahetseng mabapi le sehlahisoa sa lihlahisoa 'me u botse setsebi sa hau sa meriana kapa ngaka kapa setsebi se seng sa tlhokomelo ea bophelo pele u se sebelisa.

AE-941, Cartilage de Requin, Cartilage de Requin du Pacifique, Cartilago de Tiburon, Collagène Marin, Extrait de Cartilage de Requin, Liquide de Cartilage Marin, Marine Collagen, Lebese la Metsi a Metsing, MSI-1256F, Neovastat, Pacific Shark Cartilage, Poudre de Cartilage de Requin, Shark Cartilage Powder, Shark Cartilage ntšang, Sphyrna lewini, Squalus acanthias.

Ho ithuta haholoanyane ka hore na sengoloa sena se ngotsoe joang, ka kopo bona Meriana ea Tlhahisoleseling e Akaretsang mokhoa.

1. Mofumahali L, Smith SL. Lisebelisoa tsa pro-inflammatory tsa shark cartilage supplement. Immunopharmacol Immunotoxicol. 2015; 37: 140-7. Sheba tse sa hlakang.
2. Sakai S, Otake E, Toida T, Goda Y. Ho khetholla tšimoloho ea chondroitin sulfate ho "lijo tsa bophelo". Chem Pharm Bull (Tokyo). 2007; 55: 299-303. Sheba tse sa hlakang.
3. Boto ea Bohokahanyi ea Phekolo e Kopanetsoeng, e 'Ngoe le e Tlatsetsang. Lefufuru (Bovine le Shark) (PDQ®): Health Professional Version. Kakaretso ea tlhaiso-leseling ea mofets'e ea PDQ [Marang-rang]. Bethesda (MD): Setsi sa Kankere ea Naha (US); 2002. 2016 Jul 21. Sheba tse sa hlakang.
4. Khauta ea lefufuru ea Goldman E. Shark e lekile joalo ka kalafo ea lipale tsa psoriasis. Letlalo Litaba Tsohle 1998; 29:14.
5. Tsamaiso ea Lijo le Lithethefatsi. FDA e nka bohato khahlano le ho bapatsa ka tieo lithethefatsi tse sa lumelloeng. Pampiri ea puo ea FDA (la 10 Tšitoe 1999)
6. Lane W le Milner M. Papiso ea lefufuru la lishaka le lefufuru. Townsend Lett 1996; 153: 40-42.
7. Zhuang, L, Wang, B, Shivji, G, le et al. AE-941, inhibitor ea novel ea angiogenesis e na le phello e kholo e khahlano le ho ruruha ho hypersensitivity ea lebitso. J Sebelisa Derm 1997; 108: 633.
8. Turcotte P. Phase I thuto ea ho nyoloha ka tekanyetso ea AE-941, moemeli oa antiangiogenic, ho mokuli ea holofetseng ea amanang le lilemo. Seboka sa Mokhatlo oa Retina (Hawaii, la 2 Tšitoe 1999).
9. Phokotso DN. Mohanyetsi oa Angiogenesis e le kalafo ea psoriasis: Mokhahlelo oa I oa liteko tsa kliniki ka AE-941. Seboka sa American Academy of Dermatology, New Orleans, Louisiana, la 19 ho isa ho la 24 Hlakubele 1999.
10. Aeterna Laboratories Inc. Phase III e hlophisitsoeng ka mokhoa o ikhethileng oa AE-941 (Neovastat; Shark Cartilage Extract) ho bakuli ba nang le metastatic renal cell carcinoma ba hanyetsang ho itšireletsa mafung. 2001.
11. Escudier, B, Patenaude, F, Bukowski, R, le al. Mabaka bakeng sa teko ea bongaka ea mokhahlelo oa III le AE-941 (Neovastat (R)) ho bakuli ba renal cell carcinoma ba hanyetsang immunotherapy. Ann Oncol 2000; 11 (tlatsetso ea 4): 143-144.
12. Dupont E, Alaoui-Jamali M, Wang T, le al. Mosebetsi oa Angiostatic le antitumoral oa AE-941 (Neovastat), karoloana ea limolek'hule e tsoang lefufung la shaka. Ts'ebetso ea Mokhatlo oa Amerika oa Patlisiso ea Kankere 1997; 38: 227.
13. Shimizu-Suganuma, Masum, Mwanatambwe, Milanga, Iida, Kazum, le ba al. Phello ea lefufuru la shark ka kholo ea hlahala le nako ea ho phela ho vivo (meeting abstract). Proc Annu Kopana le Am Soc Clin Oncol 1999; 18: A1760.
14. Ha a tsejoe. Mosebetsi oa Angiostatic le antitumoral oa AE-941 (neovastat-R), karoloana ea limolek'hule e tsoang lefufung la shark (meeting abstract). Proc Annu Kopana le Am Assoc Cancer Res 1997; 38: A1530.
15. Cataldi, JM le Osborne, DL. Litlamorao tsa lefufuru la shark ho mammary tumor neovascularization ho vivo le ho ata ha sele ka vitro (meeting abstract). Tlaleho ea FASEB 1995; 9: A135.
16. Jamali MA, Riviere P, Falardeau A, le al. Phello ea AE-941 (Neovastat), angiogenesis inhibitor, ho Lewis lung carcinoma metastatic model, ufanisi, thibelo ea chefo le pholoho. Kliniki ea Invest Invest 1998; (suppl): S16.
17. Saad F, Klotz L, Babaian R, Lacombe L, Champagne P, le teko ea Dupont E. Phase I / II ho AE-941 (Neovastat) ho bakuli ba nang le mofets'e oa metastatic refractory cancer (polelo e sa hlakileng). Kopano ea selemo le selemo ea Mokhatlo oa Urological Association oa Canada (Phuptjane 24-27, 2001).
18. Rosenbluth, RJ, Jennis, AA, Cantwell, S, le al. Oral shark cartilage kalafo ea bakuli ba nang le lihlahala tse tsoetseng pele tsa boko. Boithuto ba mofofisi oa karolo ea II (seboka se sa hlakoleng). Proc Annu Kopana le Am Soc Clin Oncol 1999; 18: A554.
19. Dupont E, Savard RE, Jourdain C, Juneau C, Thibodeau A, Ross N, le al. Antiangiogenic thepa ea novel shark cartilage e ntšitsoeng: karolo e ka bang teng kalafong ea psoriasis. 1998; 2: 146-152 (Khatisitsoeng)
20. Lane IW le Contreras E. Sekhahla se phahameng sa bioactivity (phokotso ea boholo bo boholo ba hlahala) se bonoang ho bakuli ba mofets'e ba tsoetseng pele ba alafshoang ka thepa ea shark cartilage. J Naturopath Med 1992; 3: 86-88 (Khatisitsoeng)
21. Mokhatlo oa Wilson JL. Li-topical shark cartilage li kokobetsa psoriasis. Mofuta o mong oa Ther Ther 2000; 6: 291.
22. Riviere M, Latreille J, le Falardeau P. AE-941 (Neovastat), inhibitor ea angiogenesis: sephetho sa liteko tsa kankere ea karolo ea I / II ea kankere. Kankere Invest 1999; 17 (suppl 1): 16-17.
23. Milner M. Tataiso ea ts'ebeliso ea lefufuru kalafong ea ramatiki le maloetse a mang a kopaneng a ruruhileng. Amer Chiropractor 1999; 21: 40-42.
24. Leitner SP, Rothkopf MM, Haverstick DD, le al. Lithuto tse peli tsa mokhahlelo oa II oa molomo o omileng oa shark lefufuru (SCP) ho bakuli ba nang le letsoele la metastatic kapa mofetše oa senya o sa sebeliseng kalafo e tloaelehileng. Amer Soc Clin Oncol 1998; 17: A240.
25. Evans WK, Latreille J, Batist G, le et al. AE-941, inhibitor ea angiogenesis: lebaka la nts'etsopele le kopantsoe le induction chemotherapy / radiotherapy ho bakuli ba nang le mofetše o seng o monyane oa lisele tsa matšoafo (NSCLC). Lipampiri tse hlahisitsoeng 1999; S250.
26. Riviere M, Falardeau P, Latreille J, le et al. Karolo ea I / II ea kankere ea matšoafo ea liteko tsa kliniki e hlahisa AE-941 (Neovastat ®) inhibitor ea angiogenesis. Clin Invest Med (tlatsetso) 1998; S14.
27. Riviere M, Alaoui-Jamali M, Falardeau P, le al. Neovastat: inhibitor ea angiogenesis e nang le ts'ebetso e khahlanong le mofets'e. Kankere ea Proc Amer Assoc Res 1998; 39: 46.
28. Ha ho bangoli. Litlhahlobo tsa liteko tsa bongaka tsa Neovastat. 2001;
29. Aeterna Laboratories Inc. Phuputso ea Phase II ea AE-941 (Neovastat; Shark Cartilage) ho bakuli ba nang le ts'oaetso ea pele kapa ts'oaetso ea myeloma e mengata. 2001. Nomoro ea Khokahano ea Tlhahisoleseling 1-888-349-3232.
30. Felzenszwalb, I., Pelielo de Mattos, J. C., Bernardo-Filho, M., le Caldeira-de-Araujo, A. Litokisetso tse nang le lefufuru: tšireletso khahlanong le mefuta ea oksijene e sebetsang. Lijo Chem Toxicol 1998; 36: 1079-1084. Sheba tse sa bonahaleng.
31. Coppes, M. J., Anderson, R. A., Egeler, R. M., le Wolff, J. E. Mefuta e meng ea kalafo ea kalafo ea mofets'e oa bongoana. N Engl. J Med 9-17-1998; 339: 846-847. Sheba tse sa hlakang.
32. Davis, P.F, He, Y., Furneaux, R. H., Johnston, P. S., Ruger, B. M., le Slim, G. C. Ho thibela angiogenesis ka ho kenella ka molomo oa lefufuru la shark ka mokhoa oa rat. Microvasc. 1997; 54: 178-182. Sheba tse sa hlakang.
33. McGuire, T. R., Kazakoff, P. W., Hoie, E. B., le Fienhold, M. A. Mosebetsi o thibelang lefuba la shark le nang le hlahala ea necrosis factor-alpha ho mothapo oa motho oa endothelium. Pharmacotherapy 1996; 16: 237-244. Sheba tse sa hlakang.
34. Kuettner, K. E. le Pauli, B. U. Thibelo ea methapo ea methapo ka lebaka la lefufuru. Ciba e fumanoe. 1983; 100: 163-173.Sheba tse sa hlakang.
35. Lee, A. le Langer, R. Shark lefufuru le na le li-inhibitors tsa hlahala angiogenesis. Saense 9-16-1983; 221: 1185-1187. Sheba tse sa hlakang.
36. Korman, D. B. [Antiangiogenic le antitumor thepa ea lefufuru]. Vopr.Onkol. 2012; 58: 717-726. Sheba tse sa hlakang.
37. Patra, D. le Sandell, L. J. Antiangiogenic le likokoana-hloko tse thibelang kankere lefufuru. SetsebiRev. Mol. Media 2012; 14: e10. Sheba tse sa hlakang.
38. de Mejia, E. G. le Dia, V. P. Karolo ea liprotheine tsa nutraceutical le li-peptide ho apoptosis, angiogenesis, le metastasis ea lisele tsa mofetše. Kankere Metastasis Rev 2010; 29: 511-528. Sheba tse sa hlakang.
39. Bargahi, A., Hassan, Z. M., Rabbani, A., Langroudi, L., Noori, S. H., le Safari, E. Litlamorao tsa lefufuru la lishaka tse tsoang ho protheine mesebetsing ea lisele tsa NK. Emunopharmacol.Immunotoxicol. 2011; 33: 403-409. Sheba tse sa hlakang.
40. Lee, S.Y. le Chung, S. M. Neovastat (AE-941) e thibela ho ruruha ha sefofane ka khatello ea alpha ea VEGF le HIF-2. Vascul. Pharmacol 2007; 47 (5-6): 313-318 (Khatisitsoeng) Sheba tse sa hlakang.
41. Pearson, W., Orth, M. W., Karrow, N. A., Maclusky, N. J., le Lindinger, M. I. Anti-inflammatory le chondroprotective litlamorao tsa li-nutraceuticals tse tsoang ho Sasha's Blend ka mohlala oa ho phatloha ha lefufuru. Lijo tsa Mol Nutrition Res 2007; 51: 1020-1030. Sheba tse sa hlakang.
42. Kim, S., de, A., V, Bouajila, J., Dias, AG, Cyrino, FZ, Bouskela, E., Costa, PR, le Nepveu, F. Alpha-phenyl-N-tert-butyl nitrone ( Li-derivatives tsa PBN): tšebetso ea tšebetso le tšireletso khahlano le tšenyo ea likokoana-hloko tse bakoang ke ischemia / reperfusion. Bioorg. Motsoako Chem 5-15-2007; 15: 3572-3578. Sheba tse sa hlakang.
43. Merly, L., Simjee, S., le Smith, S. L. Ho hlahisoa ha li-cytokine tse ruruhang ka likarolo tsa lefufuru. Int Immunopharmacol. 2007; 7: 383-391. Sheba tse sa hlakang.
44. Moses, M. A., Sudhalter, J., le Langer, R. Ho khetholla inhibitor ea neovascularization ho lefufuru. Mahlale 6-15-1990; 248: 1408-1410. Sheba tse sa hlakang.
45. Ratel, D., Glazier, G., Provencal, M., Boivin, D., Beaulieu, E., Gingras, D., le Beliveau, R. Li-enzyme tse sebetsang ka ho otloloha tsa fibrinolytic tse ntšitsoeng ke lefu la lefufuru: mathata. Thromb.Res. 2005; 115 (1-2): 143-152. Sheba tse sa hlakang.
46. Gingras, D., Labelle, D., Nyalendo, C., Boivin, D., Demeule, M., Barthomeuf, C., le Beliveau, R. Moemeli oa antiangiogenic Neovastat (AE-941) o tsosa tšebetso ea activator ea lisele tsa plasminogen. Tsetela Lithethefatsi tse Ncha 2004; 22: 17-26. Sheba tse sa hlakang.
47. Latreille, J., Batist, G., Laberge, F., Champagne, P., Croteau, D., Falardeau, P., Levinton, C., Hariton, C., Evans, WK, le Dupont, E. Phase Teko ea I / II ea polokeho le katleho ea AE-941 (Neovastat) kalafong ea mofets'e o seng o monyane oa lisele tsa matšoafo. Kankere ea Lung Cancer 2003; 4: 231-236. Sheba tse sa hlakang.
48. Bukowski, R. M. AE-941, motsoako o sebetsang ka bongata oa antiangiogenic: liteko ho renal cell carcinoma. SetsebiOpin.Investig.Lithethefatsi 2003; 12: 1403-1411. Sheba tse sa hlakang.
49. Jagannath, S., Champagne, P., Hariton, C., le Dupont, E. Neovastat ho myeloma e mengata. Eur.J Haematol. 2003; 70: 267-268. Sheba tse sa hlakang.
50. FDA e fana ka boemo ba khutsana le lithethefatsi ho Aeterna's Neovastat bakeng sa mofetše oa liphio. Setsebi. Rev Anticancer Ther 2002; 2: 618. Sheba tse sa hlakang.
51. Dupont, E., Falardeau, P., Mousa, SA, Dimitriadou, V., Pepin, MC, Wang, T., le Alaoui-Jamali, MA Antiangiogenic le antimetastatic thepa ea Neovastat (AE-941), e nkiloeng ka molomo. e tsoang lithong tsa lefufuru. Clin Exp Metastasis 2002; 19: 145-153. Sheba tse sa hlakang.
52. Beliveau, R., Gingras, D., Kruger, EA, Lamy, S., Sirois, P., Simard, B., Sirois, MG, Tranqui, L., Baffert, F., Beaulieu, E., Dimitriadou, V., Pepin, MC, Courjal, F., Ricard, I., Poyet, P., Falardeau, P., Figg, WD, le Dupont, E. The Antiangiogenic Agent Neovastat (AE-941) E Thibela Morero oa Khōlo ea Vascular Endothelial Liphello tsa Likokoana-hloko. Kankere ea Kankere ea 2002; 8: 1242-1250. Sheba tse sa hlakang.
53. Weber, M.H, Lee, J., le Orr, F. W. Phello ea Neovastat (AE-941) molemong oa liteko tsa metastatic bone tumor. Int J Oncol 2002; 20: 299-303. Sheba tse sa hlakang.
54. Barber, R., Delahunt, B., Grebe, S. K., Davis, P. F., Thornton, A., le Slim, G. C. Oral shark cartilage ha e felise carcinogenesis empa e liehisa tsoelo-pele ea hlahala ea mofuta oa murine. Kopano ea likokoana-hloko Res 2001; 21 (2A): 1065-1069. Sheba tse sa hlakang.
55. Gonzalez, RP, Soares, FS, Farias, RF, Pessoa, C., Leyva, A., Barros Viana, GS le Moraes. cornea. Pholo. Pholo. 2001; 24: 151-154. Sheba tse sa hlakang.
56. Brem, H. le Folkman, J. Thibelo ea hlahala angiogenesis e kenelletsoeng ke lefufuru. J Hlahisa Med 2-1-175; 141: 427-439. Sheba tse sa hlakang.
57. Koch, A. E. Karolo ea angiogenesis ho ramatiki ea ramatiki: liphetoho tsa morao tjena. Monghali Rheum. 2000; 59 Tlatsetso ea 1: i65-i71. Sheba tse sa hlakang.
58. Lipuo, K. L. le Harris, A. L. Boemo ba hajoale ba lintlha tsa antiangiogenic. Br J Haematol. 2000; 109: 477-489. Sheba tse sa hlakang.
59. Morris, G. M., Coderre, J. A., Micca, P. L., Lombardo, D.T, le Hopewell, J. W. Boron neutron kalafo ea kalafo ea rat 9L gliosarcoma: tlhahlobo ea litlamorao tsa lefufuru. Br J Radiol. 2000; 73: 429-434. Sheba tse sa hlakang.
60. Renckens, C.N le van Dam, F. S. [Letlole la naha la mofets'e (Koningin Wilhelmina Fonds) le kalafo ea Houtsmuller bakeng sa mofets'e]. Ned.Tijdschr.Geneeskd. 7-3-1999; 143: 1431-1433. Sheba tse sa hlakang.
61. Moses, MA, Wiederschain, D., Wu, I., Fernandez, CA, Ghazizadeh, V., Lane, WS, Flynn, E., Sytkowski, A., Tao, T., le Langer, R. Troponin I ke e teng lefufuru la motho mme e thibela angiogenesis. Proc Natl.Acad.Sci.U.S. 3-16-1999; 96: 2645-2650. Sheba tse sa hlakang.
62. Moller HJ, Moller-Pedersen T, Damsgaard TE, Poulsen JH. Pontšo ea immunogenic keratin sulphate khoebong ea chondroitin 6-sulfate e tsoang lefung la shark. Litlamorao bakeng sa liteko tsa ELISA. Kliniki Chim Acta 1995; 236: 195-204. Sheba tse sa hlakang.
63. Lu C, Lee JJ, Komaki R, le al. Chemoradiotherapy e nang le AE-941 kapa ntle le eona ketsahalong ea III ea mofets'e oa lisele tsa lisele tse nyane. J Natl Kankere Inst 2010; 102: 1-7. Sheba tse sa hlakang.
64. Loprinzi CL, Levitt R, Barton DL, le al. Tlhatlhobo ea lefu la shark ho bakuli ba nang le mofetše o tsoetseng pele: teko ea sehlopha sa kalafo ea mofets'e sa North Central Kankere 2005; 104: 176-82. Sheba tse sa hlakang.
65. Batist G, Patenaude F, Champagne P, le al. Neovastat (AE-941) ho bakuli ba renal cell carcinoma: tlaleho ea teko ea phase II e nang le litekanyetso tse peli tsa tekanyetso. Ann Oncol 2002; 13: 1259-63 .. Sheba tse hlakileng.
66. Sauder DN, Dekoven J, Champagne P, le al. Neovastat (AE-941), inhibitor ea angiogenesis: Teko ea kliniki ea I / II ea liteko tse etsahalang ho bakuli e nang le plaque psoriasis. J Ke Acad Dermatol 2002; 47: 535-41. Sheba tse sa hlakang.
67. Gingras D, Renaud A, Mousseau N, le al. Matrix proteinase inhibition ea AE-941, motsoako o sebetsang ka bongata oa antiangiogenic. Anticancer Res 2001; 21: 145-55 .. Sheba tse sa hlakang.
68. Falardeau P, Champagne P, Poyet P, le al. Neovastat, sethethefatsi sa antiangiogenic se sebetsang ka tlhaho, litekong tsa bongaka tsa mokhahlelo oa III. Semin Oncol 2001; 28: 620-5 .. Sheba tse sa hlakang.
69. Boivin D, Gendron S, Beaulieu E, le al. Moemeli oa antiangiogenic Neovastat (AE-941) o susumetsa endothelial cell apoptosis. Kankere ea Mol Cancer 2002; 1: 795-802 .. Sheba tse ling.
70. Cohen M, Wolfe R, Mai T, Lewis D. Teko e laoloang ka tsela e sa sebetseng, e habeli e foufetseng, e nang le placebo ea tranelate ea lihlooho tse nang le glucosamine sulfate, chondroitin sulfate le camphor ea lefu la masapo a mangole. J Rheumatol 2003; 30: 523-8 .. Sheba tse hlakileng.
71. May B, Kuntz HD, Kieser M, Kohler S. Ts'ebetso e ntle ea peppermint oli / caraway oli e kopaneng ho bao e seng seso sa dyspepsia. Arzneimittelforschung 1996; 46: 1149-53 (Khatisitsoeng) Sheba tse sa hlakang.
72. Anon. AEterna e phatlalatsa ho qala ha ngoliso ea mokuli bakeng sa teko ea bongaka ea bongaka ea AE-941 / Neovastat e tšehelitsoeng ke NIH - kalafo ea mofetše oa matšoafo. Phatlalatso ea Litaba ea Aeterna 2000 2000 Mots'eanong 17.
73. Sheu JR, Fu CC, Tsai ML, Chung WJ. Phello ea U-995, e leng matla a shark cartilage a tsoang angiogenesis inhibitor, mesebetsing ea anti-angiogenesis le anti-tumor. Setsi sa likokoana-hloko Res 1998; 18: 4435-41. Sheba tse sa hlakang.
74. Fontenele JB, Viana GS, Xavier-Filho J, de-Alencar JW. Ketso e khahlano le ho ruruha le analgesic ea karoloana e qhibilihang ka har'a metsi e tsoang lefufuru. Braz J Med Biol Res. 1996; 29: 643-6. Sheba tse sa hlakang.
75. Fontenele JB, Araujo GB, ea Alencar JW, Viana GS. Litholoana tsa analgesic le li-anti-inflammatory tsa shark lefufuru li bakoa ke molek'hule ea peptide mme li its'etlehile ka sistimi ea nitric oxide (NO). Biol Pharm Bull 1997; 20: 1151-4. Sheba tse sa hlakang.
76. Gomes EM, Souto PR, Felzenszwalb I. Shark-cartilage e nang le litokisetso e sireletsa lisele khahlanong le hydrogen peroxide e bakiloeng ke tšenyo le mutagenesis. Mutat Res 1996; 367: 204-8. Sheba tse sa hlakang.
77. Mathews J. Media e fepa moferefere ka lefufuru la shark joalo ka kalafo ea mofets'e. J Natl Kankere Inst 1993; 85: 1190-1. Sheba tse sa hlakang.
78. Bhargava P, Trocky N, Marshall J, le al. Karolo ea I polokeho, mamello le thuto ea meriana ea phallo e eketsehang, ho eketseha ha nako e telele ho tšeloa ha MSI-1256F (Squalamine Lactate) ho bakuli ba nang le mofetše o tsoetseng pele. Proc Am Soc Clinical Oncol 1999; 18: A698.
79. Kalidas M, Hammond LA, Patnaik P, le al. Karolo ea I le thuto ea pharmacokinetic (PK) ea angiogenesis inhibitor, squalamine lactate (MSI-1256F). Proc Am Soc Clinical Oncol 2000; 19: A698.
80. Patnaik A, Rowinsky E, Hammond L, le al. Karolo ea I le thuto ea pharmacokinetic (PK) ea angiogenesis inhibitor e ikhethang, squalamine lactate (MSI-1256F). Proc Am Soc Clinical Oncol 1999; 18: A622.
81. Evans WK, Latreille J, Batist G, le al. AE-941, inhibitor ea angiogenesis: lebaka la nts'etsopele le kopantsoe le induction chemotherapy / radiotherapy ho bakuli ba nang le mofets'e o monyane oa lisele tsa matšoafo (NSCLC). Proc Am Soc Clinical Oncol 1999; 18: A1938 (Khatisitsoeng)
82. Rosenbluth RJ, Jennis AA, Cantwell S, DeVries J. Oral shark lefufuru kalafong ea bakuli ba nang le lihlahala tse tsoetseng pele tsa boko. Thuto ea mofofisi oa karolo ea II. Proc Am Soc Clinical Oncol 1999; 18: A554 (Khatisitsoeng)
83. Leitner SP, Rothkopf MM, Haverstick L, le al. Lithuto tse peli tsa mokhahlelo oa bobeli oa molomo o omileng oa shark lefufuru (SCP) ho bakuli (pts) ba nang le letsoele la metastatic kapa mofetše oa senya o sa sebeliseng kalafo e tloaelehileng. Proc Am Soc Clinical Oncol 1998; 17: A240.
84. Mokhatlo oa Natl CancerNet. Webete ea lefuba: www.cancer.gov (E fihliloe ka la 18 Phato 2000).
85. Berbari P, Thibodeau A, Germain L, et al Antiangiogenic litlamorao tsa taolo ea molomo ea lero la lefufuru le tsoang bathong. J Surg Res 1999; 87: 108-13. Sheba tse sa hlakang.
86. Hillman JD, Peng AT, Gilliam AC, Remick SC. Kalafo ea Kaposi Sarcoma ka tsamaiso ea molomo ea lefu la shark ka har'a kokoana-hloko ea Human Herpes 8-seropositive, Human Immunodeficiency Virus-Seronegative bosodoma monna. Arch Dermatol 2001; 137: 1149-52 (Khatisitsoeng) Sheba tse sa hlakang.
87. Litlhahlobo tsa liteko tsa bongaka tsa Neovastat. E hlahisoa kopanong ea selemo le selemo ea Mokhatlo oa Amerika oa Patlisiso ea Kankere. La 27 Hlakubele 2001.
88. Mokhatlo oa Wilson JL. Topical shark cartilage e hlōla psoriasis: tlhahlobo ea lipatlisiso le liphetho tsa pele tsa bongaka. Tlatsetso e 'ngoe Ther 2000; 6: 291.
89. Miller DR, Anderson GT, Stark JJ, le al. Teko ea Karolo ea I / II ea polokeho le katleho ea lefufuru la shark kalafong ea mofetše o tsoetseng pele. J Kliniki ea Oncol 1998; 16: 3649-55. Sheba tse sa hlakang.
90. Lane IW, Comac L. Sharks ha ba tšoaroe ke mofetše. Garden City, NY: Sehlopha sa Avery Publishing; 1992.
91. Hunt TJ, Connelly JF. Lefufuru la Shark bakeng sa kalafo ea mofets'e. Ke J Health Syst Pharm 1995; 52: 1756-60. Sheba tse sa hlakang.
92. Ashar B, Vargo E. Shark lefu le bakoang ke lefu la lefuba [lengolo]. Ann Intern Med 1996; 125: 780-1 (Khatisitsoeng) Sheba tse sa hlakang.

Qetellong ho hlahlojoa - 03/14/2019